Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year



Merger | Acquired

About Contral Clinics

Provider of a unique treatment method for excessive drinking, alcohol abuse and alcoholism based on a recent breakthrough in alcoholism research. The company's treatment does not interfere with everyday life but allows people to live normally while undergoing the program. The treatment consists of a combination of the drug naltrexone and professional counselling. Naltrexone, together with the counselling, diminishes alcohol craving without causing unpleasant side effects.

Contral Clinics Headquarter Location

Kappelitie 6 A

Espoo, 02200,


358 9 4357 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.